Risk Factora | Urine culture positive | Urine culture negative | OR (95% CI) | P value |
---|---|---|---|---|
N | 57 | 232 | Â | Â |
Demographics | ||||
Age | 49.1 (13.8) | 47.9 (13.8) | Â | 0.59 |
Male | 40 (70) | 158 (68) | Â | 0.76 |
Race/Ethnicity | Â | Â | Â | 0.10 |
   Black | 26 (46) | 141 (61) |  |  |
   Hispanic | 14 (25) | 39 (17) |  |  |
   Other Race | 4 (7) | 21 (9) |  |  |
   White | 13 (22) | 31 (13) |  |  |
Microbiological factor | ||||
   Epidemiological Risk |  |  |  |  |
   Community onset | 26 (46) | 54 (23) |  | <0.001 |
   Healthcare associated | 18 (32) | 61 (26) |  |  |
   Hospital onset | 13 (23) | 117 (50) |  |  |
MRSA | 21 (37) | 99(43) | Â | 0.42 |
Clinical Factors | ||||
Immunosuppressed | 9 (16) | 44 (19) | Â | 0.58 |
Incubation Period | 15.7 (30.5) | 13.8 (33.4) | Â | 0.68 |
Charlson Score | 2.05 | 2.15 | Â | 0.801 |
Hemodialysis | 3 (5) | 24 (10) | Â | 0.24 |
HIV | 11 (19) | 23 (10) | 2.17 (1.00 - 4.77) | 0.05 |
Endocarditis | 7 (12) | 17 (7) | Â | 0.22 |
Bladder catheter | 20 (35) | 85 (37) | Â | 0.83 |
Urological surgery | 6 (11) | 7 (3) | 3.78 (1.22 - 11.73) | 0.03 |
DM | 19 (33) | 64 (28) | Â | 0.39 |
IVDA | 7 (12) | 39 (17) | Â | 0.40 |
Prosthetic device | 11 (19) | 55 (24) | Â | 0.48 |
Alcoholism | 11 (19) | 36 (16) | Â | 0.49 |
Line infection/phlebitis | 6 (11) | 52 (22) | 0.41 (0.17 - 1.00) | 0.05 |
Skin soft tissue infection | 10 (18) | 47 (20) | Â | 0.64 |
Bone/joint infection | 7 (12) | 20 (9) | Â | 0.39 |
Pulmonary infection | 12 (21) | 29 (13) | 1.87 (0.89 - 3.94) | 0.10 |
GU infection | 12 (21) | 10 (4) | 5.92 (2.41 - 14.54) | <0.001 |